Skip to main content
. 2021 Jun 4;134(12):1405–1415. doi: 10.1097/CM9.0000000000001586

Table 1.

Characteristics of infertility patients who conducted IVF/ICSI.

Variable Live birth (n = 8928) Non-live birth (n = 9050) Total (n = 17,978) P
Female age (years) 30.81 ± 4.05 33.09 ± 5.13 31.96 ± 4.76 <0.001
Male age (years) 32.50 ± 5.08 34.65 ± 6.03 33.58 ± 5.68 <0.001
BMI of female (kg/m2) 22.33 ± 3.35 22.75 ± 3.61 22.54 ± 3.48 <0.001
Average duration of infertility (years) 4.22 ± 3.11 5.06 ± 4.08 4.65 ± 3.66 <0.001
Classification of infertility <0.001
 Tubal factor 3505 3014 6519
 Ovulatory dysfunction 247 401 648
 Endometriosis 126 115 241
 Confounding factor in female 585 747 1332
 Other female factor 82 147 229
 Cofounding factor in the couple 1363 1839 3202
 Male factor only 2476 2175 4651
 Unexplained infertility 544 612 1156
Preliminary gonadotropin used <0.001
 FSH + HMG 3397 4527 7924
 FSH 5440 4282 9722
HMG 91 241 332
Duration of stimulation (days) 12.07 ± 2.48 12.02 ± 2.67 12.05 ± 2.58 0.267
Number of gonadotropin units used 2597.86 ± 1141.70 3165.42 ± 1456.20 2883.44 ± 1339.79 <0.001
COH protocol <0.001
 Long protocol 4713 4177 8890
 Ultra-long protocol 1240 1311 2551
 Short protocol 755 1252 2007
 Antagonist protocol 2220 2310 4530
Number of oocytes retrieved 15.35 ± 7.98 11.35 ± 7.60 13.34 ± 8.04 <0.001
Number of transferrable embryos 6.66 ± 5.19 3.62 ± 3.51 10.18 ± 4.35 <0.001

Data are presented as n or mean ± standard deviation. BMI: Body mass index; COH: Controlled ovarian hyperstimulation; FSH: Follicle-stimulating hormone; HMG: Human menopausal gonadotropin; ICSI: Intracytoplasmic sperm injection; IVF: In vitro fertilization.